Drug maker Biogen Idec building an open campus in an effort to reflect its corporate culture

Photos by Jessica Rinaldi For The Boston Globe

This is a summary. To read the whole story subscribe to

Can office architecture drive corporate culture?

Biogen Idec Inc., the largest Massachusetts-based biotech company, is about to find out.

Starting this week, about 300 employees are moving from older offices on the company’s Kendall Square research and manufacturing campus to the first of two new buildings opening this year. Building 9, as the six-story, 190,000-square-foot complex is called, will house drug development operations, including a preclinical group managing toxicology studies, a regulatory group responsible for government filings, and data managers who track clinical trials.

Their new “open space” is a radical departure from operations elsewhere at Biogen Idec. Building 9 has no private offices, just individually designed workstations and common “huddle rooms” where employees can talk on the phone or have small meetings.

Full story for subscribers.

Get the full story with unlimited access to

Just 99 cents for four weeks.